| Low molecular weight heparins in clinical practice: unsolved or partially solved problems. | |
| | |
MedLine Citation:
|
PMID: 9656086 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Low molecular weight heparins (LMWH) have been shown, in recent years, to be at least as effective as standard heparin (SH) in the prophylaxis and treatment of venous thrombosis. In spite of several studies there are still some unsolved problems to be dealt with. These may be summarized along the following lines: 1) Side effect; 2) Use in pregnancy; 3) Role in arterial thrombosis; 4) Use in severe deep venous thrombosis; 5) Use for home treatment; 6) Effect on cancer related mortality; 7) Standardization of preparations; 8) Dosage uncertainties; 9) Long term treatment. The two most important aspects are those pertaining to the potential use in arterial thrombosis and the possibility of home treatment of selected patients with venous thromboembolism. A few studies now indicate that LMWH may play an important role in several arterial thrombosis (coronary disease, ischemic stroke, etc). As far as the indications for home treatment are concerned, recent studies have given a positive answer. However, rather than home treatment it would be more appropriate to refer to early discharge from the hospital. The overall impression is that LMWH may represent an important progress in the management and prophylaxis of thrombotic disease. |
| | |
Authors:
|
A Girolami |
Related Documents
:
|
19844176 - Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vei... 8839396 - Uses of low-molecular-weight heparin. 11697716 - Low-molecular-weight heparins: weeks or months instead of days of treatment. 4030846 - Heparin and dihydroergotamine prophylaxis against thrombo-embolism after hip arthroplasty. 15504716 - The roles of electroencephalography and neuroimaging in children with holoprosencephaly. 23420256 - Review: etomidate increased mortality and adrenal insufficiency in adults with sepsis. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: Archivos del Instituto de Cardiología de México Volume: 68 ISSN: 0020-3785 ISO Abbreviation: Arch Inst Cardiol Mex Publication Date: 1998 Jan-Feb |
Date Detail:
|
Created Date: 1998-08-14 Completed Date: 1998-08-14 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0400463 Medline TA: Arch Inst Cardiol Mex Country: MEXICO |
Other Details:
|
Languages: eng Pagination: 69-76 Citation Subset: IM |
Affiliation:
|
University of Padua Medical School, II Chair of Internal Medicine, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Clinical Trials as Topic Female Heparin, Low-Molecular-Weight / administration & dosage, adverse effects, therapeutic use* Humans Male Neoplasms / complications Outpatients Pregnancy Randomized Controlled Trials as Topic Thromboembolism / prevention & control Thrombophlebitis / drug therapy Thrombosis / drug therapy, prevention & control Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Heparin, Low-Molecular-Weight |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cardiac tamponade in newborn infants with central venous catheter receiving parenteral nutrition
Next Document: Computer-administered rating scales for social anxiety in a clinical drug trial.